|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ROBERT L. EHRLICH, JR., Governor
|
|
|
|
|
|
H.B. 317
|
|
|
|
|
|
|
|
|
|
|
|
|
(4) the Executive Director of the State Board of Pharmacy, or the
Executive Director's designee;
(5) the Executive Director of the Maryland Health Insurance Plan, or the
Executive Director's designee; and one representative of the Board of Directors for the
Maryland Health Insurance Plan, as determined by the Chairman of the Board of
Directors;
(4) one representative of the State Board of Pharmacy, as determined by
the President of the State Board of Pharmacy;
(5) the following two members, appointed by the Secretary of Health and
Mental Hygiene:
(i) one representative of the Maryland Medical Assistance Program
in the Department of Health and Mental Hygiene; and
(ii) one representative of the Office of Health Care Quality in the
Department of Health and Mental Hygiene; and
(6) the following six eight members, appointed by the Governor:
(i) one representative of the American Cancer Society;
(ii) one hospital representative;
(iii) one nursing home representative;
(iv) one representative of a community health center;
(v) one pharmacy representative; and
(vi) one representative of the Medbank Program;
(vii) one representative of the pharmaceutical industry; and
(viii) one representative of the University of Maryland School of
Pharmacy.
(c) The members shall elect a chair from among the members.
(d) The Department of Health and Mental Hygiene shall provide staff for the
Task Force.
(e) A member of the Task Force may not receive compensation.
(f) The Task Force shall:
(1) study and make recommendations regarding the establishment of a
Prescription Drug Repository Program in the State, including:
(i) types of drugs that may be donated to the Program;
(ii) types of drugs that may not be donated to the Program;
(iii) who may donate drugs to the Program;
- 4047 -
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
